WuXi AppTec's latest marketcap:
As of 07/28/2025, WuXi AppTec's market capitalization has reached $35.31 B. According to our data, WuXi AppTec is the 634th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 35.31 B |
| Revenue (ttm) | 5.52 B |
| Net Income (ttm) | 1.56 B |
| Shares Out | 2.85 B |
| EPS (ttm) | 0.45 |
| Forward PE | 20.41 |
| Ex-Dividend Date | 05/21/2025 |
| Earnings Date | 07/27/2025 |
WuXi AppTec's yearly market capitalization.
| Date | Market Cap(¥) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/28/2025 | ¥253.34 B | $35.31 B | 60.14% | 634 |
| 12/31/2024 | ¥158.2 B | $21.67 B | -26.67% | 873 |
| 12/29/2023 | ¥215.75 B | $30.39 B | -8.82% | 603 |
| 12/30/2022 | ¥236.61 B | $34.29 B | -31.83% | 479 |
| 12/31/2021 | ¥347.12 B | $54.63 B | 6.21% | 336 |
| 12/31/2020 | ¥326.83 B | $50.07 B | 117.98% | 315 |
| 12/31/2019 | ¥149.93 B | $21.53 B | 75.72% | 667 |
| 12/28/2018 | ¥85.33 B | $12.41 B | 901 |
Company Profile
About WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd. is an investment holding company specializing in research and manufacturing services for small molecule drugs and advanced therapies. Headquartered in Shanghai, China, the company operates globally, serving clients in the United States, Europe, and other international markets.
Business Segments
The company operates through six key segments:
- WuXi Chemistry – Contract research, development, and manufacturing for synthetic molecular modalities.
- WuXi Testing – Preclinical to clinical trial testing services for drugs and medical devices.
- WuXi Biology – Biology services supporting drug discovery and development.
- WuXi ATU – End-to-end solutions for cell and gene therapies.
- WuXi DDSU – Drug discovery services for pharmaceutical and biotech clients.
- Others – Additional services including consulting, software development, and clinical research.
Services & Solutions
The company provides a comprehensive range of services, including:
- Contract research, development, and manufacturing (CRDMO) for small molecules, oligonucleotides, peptides, and complex conjugates.
- Integrated drug discovery and development support from target identification to clinical trials.
- Preclinical and clinical testing for pharmaceuticals and medical devices.
- Combinatorial chemistry and pharmaceutical consulting.
- Pharmacology, toxicology, and safety evaluation research.
- New drug clinical development and trial management.
Company Background
Founded in 2000, WuXi AppTec has grown into a leading global provider of drug development and manufacturing services, leveraging cutting-edge technology and innovation to accelerate the delivery of life-saving therapies.
Frequently Asked Questions
-
What is WuXi AppTec's (SHA-603259) current market cap?As of 07/28/2025, WuXi AppTec (including the parent company, if applicable) has an estimated market capitalization of $35.31 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does WuXi AppTec (SHA-603259) rank globally by market cap?WuXi AppTec global market capitalization ranking is approximately 634 as of 07/28/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.